Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, May 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 335 articles:
HTML format


 

Single Articles

  1. ZHAO N, Gao Y, Li F, Shi J, et al
    Detection of precancerous lesions in cervical images of perimenopausal women using U-net deep learning.
    Afr J Reprod Health. 2025;29:108-119.
    PubMed    
    Abstract available

  2. LAYET F, Murungi T, Ashaba N, Nakayita RM, et al
    Knowledge, Practices, and Perceptions of the Healthcare Providers on Cervical Cancer Screening Among HIV-Positive Women at Lira Regional Referral Hospital, Lira City.
    Biomed Res Int. 2025;2025:1156001.
    PubMed    
    Abstract available

  3. KUMAR A
    ZINC1797251, a novel natural product small molecule targets viral oncoprotein E6 in human papillomavirus-16 positive cervical cancer cells.
    J Biomol Struct Dyn. 2025 May 1:1-13. doi: 10.1080/07391102.2025.2497459.
    PubMed    
    Abstract available

  4. GAO X, Fu S, Yang C, Jiang W, et al
    Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic Squamous Cell Carcinoma of Unknown Primary.
    Cancer Med. 2025;14:e70869.
    PubMed    
    Abstract available

  5. GROSSI FS, Balbinotti RR, Muller GC, Chagas LB, et al
    Comparative efficacy of non-ablative radiofrequency and promestriene in management of the genitourinary syndrome and sexual dysfunction in cervical cancer survivors: a pilot randomized trial.
    J Sex Med. 2025 May 2:qdaf083. doi: 10.1093.
    PubMed    
    Abstract available

  6. IWELUNMOR J, Wapmuk AE, Kokelu E, Ojo T, et al
    For girls and women (4GW) HPV RCT protocol: a crowdsourced, pragmatic stepped-wedge cluster randomized trial to improve uptake of HPV vaccination and screening among mother-daughter dyads in Nigeria.
    Implement Sci. 2025;20:18.
    PubMed    
    Abstract available

  7. ZHU Y, Tan H
    Letter to the editor "Prognosis and treatment regimens for patients with different lymph node statuses in locally advanced cervical cancer".
    Eur J Surg Oncol. 2025 Apr 25:110098. doi: 10.1016/j.ejso.2025.110098.
    PubMed    


  8. ORJI AF, Drews-Botsch C, Turpin R, Gimm G, et al
    Examining disparities in cervical cancer diagnosis at the intersection of disability and sexual orientation.
    Disabil Health J. 2025 Apr 23:101838. doi: 10.1016/j.dhjo.2025.101838.
    PubMed    
    Abstract available

  9. BOEMI S, Guagliardo G, Pasi S, Somma M, et al
    Magnetic Resonance Imaging in the Management of Women with Low-Risk Early-Stage Cervical Cancer: A Narrative Review.
    Diagnostics (Basel). 2025;15:985.
    PubMed    
    Abstract available

  10. KJAER SK
    [From hypothesis to prevention of HPV and cervical cancer].
    Ugeskr Laeger. 2025;187:V07240716.
    PubMed    
    Abstract available

  11. BIGAARD J, Kjaer SK, Andersen B
    [The elimination of cervical cancer in Denmark].
    Ugeskr Laeger. 2025;187:V08240524.
    PubMed    
    Abstract available

  12. MA CY, Shang J, Zhang L, Chen J, et al
    Anxiety, depression, and coping styles among cervical cancer patients during radiotherapy and their correlations with uncertainty in illness.
    World J Psychiatry. 2025;15:103510.
    PubMed    
    Abstract available

  13. ZAMMIT M, Nyaberi J, Mambo S, Otieno C, et al
    Individual-Level Factors that Contribute to Delayed Cervical Cancer Diagnosis among Patients in Kenya; A Hospital-Based Assessment.
    J Cancer Sci Clin Ther. 2024;8:jcsct.
    PubMed    
    Abstract available

  14. BOUQUET JM, Morris E, Zapata I
    A novel and cost-effective model to screen and treat cervical cancer and precancers at the point of care.
    Front Public Health. 2025;13:1527172.
    PubMed    
    Abstract available

  15. BAO K, Zhang X, Bao L, Tao X, et al
    MiR-484 Regulates the IL-6/STAT3 Signaling Pathway by Down-Regulating KLF12 to Inhibit the Malignant Progression of Cervical Cancer.
    Int J Womens Health. 2025;17:1165-1174.
    PubMed    
    Abstract available

  16. LI J, Zhao X, Li X, Lin K, et al
    Analysis of the disease burden of malignancies in the female reproductive system in China from 1990 to 2019: an age-period-cohort study and joinpoint analysis.
    BMJ Open. 2025;15:e081511.
    PubMed    
    Abstract available

  17. WANG X, Li Q, Liu J, Xie C, et al
    Harnessing nano-delivery systems to un-cover the challenges for cervical cancer therapy.
    Int J Pharm. 2025 Apr 28:125657. doi: 10.1016/j.ijpharm.2025.125657.
    PubMed    
    Abstract available

  18. BOAMAH MENSAH AB, Konney TO, Adankwah E, Amuasi J, et al
    Perceptions of barriers and facilitators for cervical cancer screening from women and healthcare workers in Ghana: Applying the Dynamic Sustainability Framework.
    PLOS Glob Public Health. 2025;5:e0003011.
    PubMed    
    Abstract available

  19. PATHAK SO, Manohar SM
    ONC201 (Dordaviprone) Induces Integrated Stress Response and Death in Cervical Cancer Cells.
    Biomolecules. 2025;15:463.
    PubMed    
    Abstract available

  20. LIU T, Liang H, Li Y, Liao W, et al
    The increased matrix stiffness caused by LOXL2 activates Piezo1 channels to promote the migration and invasion of cervical cancer cells.
    Discov Oncol. 2025;16:644.
    PubMed    
    Abstract available

  21. WODAJO MZ, Mavhandu-Mudzusi AH, Adekola AP, Matakanye H, et al
    Optimising the effectiveness of the see and treat program for cervical intracellular neoplasia among HIV-positive women, Addis Ababa Ethiopia.
    Afr J Reprod Health. 2025;29:16-27.
    PubMed    
    Abstract available

  22. PENA S, Singh M, Rojo I, Lezameta AB, et al
    Determinants of Cervical Cancer Screening in Latina Women.
    Hisp Health Care Int. 2025 Apr 30:15404153251339806.
    PubMed    
    Abstract available


  23. RETRACTION: miR-25-3p Reverses Epithelial-Mesenchymal Transition via Targeting Sema4C in Cisplatin-Resistance Cervical Cancer Cells.
    Cancer Sci. 2025 Apr 30. doi: 10.1111/cas.70083.
    PubMed    
    Abstract available

  24. WANG J, An W, Pang Z, Zhao M, et al
    The TFRC as a prognostic biomarker and potential therapeutic target in cervical cancer: a preliminary study.
    Front Oncol. 2025;15:1523137.
    PubMed    
    Abstract available

  25. HOU Y, Zhang L, Wang W, Cheng K, et al
    Down-regulation of miR-125b by HPV16 E6 might promote cervical cancer progression through TAZ/TEAD.
    Front Oncol. 2025;15:1444874.
    PubMed    
    Abstract available

  26. XU H, Zhang D, Zhang Y, Chen Y, et al
    TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis.
    Theranostics. 2025;15:5420-5439.
    PubMed    
    Abstract available

  27. DU K, Chen Q, Fan H, Lei Y, et al
    Construction of a Prognostic Model for Cervical Cancer Related to lncRNA Based on Differential Co-expression Network and Functional Study of Key Gene EGFR-AS1.
    J Cancer. 2025;16:2321-2338.
    PubMed    
    Abstract available

  28. SUHAIRI SS, Chui PL, Abdul Hadi H, Kon YY, et al
    Knowledge of breast and cervical cancer symptoms and perceived barriers to seek treatment among urban underserved women.
    Women Health. 2025 Apr 30:1-12. doi: 10.1080/03630242.2025.2496933.
    PubMed    
    Abstract available

  29. ATTEIA G, Alabdulhafith M, Abdallah HA, Abdel Samee N, et al
    Deep learning-based decision support system for cervical cancer identification in liquid-based cytology pap smears.
    Technol Health Care. 2025 Apr 30:9287329251330081.
    PubMed    
    Abstract available

  30. GONCALVES E, Fontes F, Rodrigues JR, Calisto R, et al
    Risk and survival of third primary cancers in a population-based cohort of patients with a cervical, endometrial, or ovarian cancer.
    J Obstet Gynaecol Res. 2025;51:e16297.
    PubMed    
    Abstract available

  31. ABD EL HAMID DM, Riad AY, Mosalam NA, Ahmed SH, et al
    Phase II Study to Evaluate the Safety and Efficacy of Neoadjuvant Chemotherapy with Weekly Paclitaxel and Carboplatin Followed by Radical Chemoradiation in Locally Advanced Cervical Cancer in Egyptian Population.
    Asian Pac J Cancer Prev. 2025;26:1459-1468.
    PubMed    
    Abstract available

  32. WAIKETKARN A, Promchit K, Thitvirachawat S, Suwannarurk K, et al
    Experience of Cervical Cytology and High-Risk HPV Testing (Physician vs Self-Collected) for Primary Cervical Cancer Screening in an Urban Hospital of Thailand.
    Asian Pac J Cancer Prev. 2025;26:1401-1405.
    PubMed    
    Abstract available

  33. PASANE J, Sriwatana K, Krasairsom K, Suwunnapang N, et al
    Incidence and Survival Trends of Cervical Cancer in Khon Kaen, Thailand.
    Asian Pac J Cancer Prev. 2025;26:1393-1400.
    PubMed    
    Abstract available

  34. KHUDHUR RK, Yahiya YI, Majeed AH, Yasin YS, et al
    Scrutiny of the Co-Cytotoxic Impact of Metformin-Omeprazole on the Cervical Cancer Cell Line and Their Aptitude to Target Heat Shock 60.
    Asian Pac J Cancer Prev. 2025;26:1353-1363.
    PubMed    
    Abstract available

  35. SUDHAGER A, Vallath N, Krishnatry R, Balasubramani L, et al
    Awareness about Cervical Cancer and Acceptance of Pap Smear for Screening among Women Attending a Tertiary Care Center.
    Asian Pac J Cancer Prev. 2025;26:1209-1217.
    PubMed    
    Abstract available

  36. FU J, Li P, Yao J, Wang Z, et al
    The potential for de-escalation radical surgery in women with stage IB2 cervical cancer (FIGO 2018): a multi-institutional experience of 63,926 cases over a 14-year period in China.
    BMC Surg. 2025;25:187.
    PubMed    
    Abstract available

  37. BAJWA HK, Beriwal S, Natte R, Kumar RC, et al
    A dosimetric evaluation of ureteric doses with and without ureter as avoidance organ in patients treated with MR hybrid brachytherapy for cervical cancer.
    Brachytherapy. 2025 Apr 28:S1538-4721(25)00039.
    PubMed    
    Abstract available

  38. JOSEPH A, Nwachukwu C, Adegboyega B, Salako O, et al
    3D HDR brachytherapy for cervical cancer in LMIC: Audit of a single institution experience in Lagos, Nigeria.
    Brachytherapy. 2025 Apr 28:S1538-4721(25)00016.
    PubMed    
    Abstract available

  39. CHEN Y, Zhong D
    Mendelian randomization reveals immune cell composition as a key determinant of cervical cancer prognosis.
    Discov Oncol. 2025;16:635.
    PubMed    
    Abstract available

  40. ALLALI M, El Fermi R, Errafii K, Abdelaziz W, et al
    HPV genotypes in Africa: comprehensive analysis of genetic diversity and evolutionary dynamics.
    Arch Virol. 2025;170:116.
    PubMed    
    Abstract available

  41. MUKHERJEE A, Manna S, Singh A, Ray A, et al
    Investigating Cisplatin Resistance in Squamous Cervical Cancer: Proteomic Insights into DNA Repair Pathways and Omics-Based Drug Repurposing.
    J Proteome Res. 2025 Apr 29. doi: 10.1021/acs.jproteome.4c00885.
    PubMed    
    Abstract available

  42. VARGAS-CRUZ SL, Velasquez-Jimenez CM, Fandino-Osorio V, Sarmiento-Medina M, et al
    [Educational strategy for prevention of cervical cancer in Indigenous peoples: a participatory action research experience].
    Cad Saude Publica. 2025;41:e00170423.
    PubMed    
    Abstract available

  43. SCHAEFER A, Rockson A, Islam JY, LaForest M, et al
    Structural Racism in Cervical Cancer Care and Survival Outcomes: A Systematic Review of Inequities and Barriers.
    Curr Epidemiol Rep. 2025;12:7.
    PubMed    
    Abstract available

  44. TIAN W, Du Y, Zhou P, Ren H, et al
    Dosimetric evaluation of image-guided adaptive radiotherapy for locally advanced cervical cancer.
    Medicine (Baltimore). 2025;104:e42280.
    PubMed    
    Abstract available

  45. ZHANG Y, Zhang Y, Hu T, Pu X, et al
    Effect of HPV integration on prognosis of young women with CIN2 in China: protocol for a multicentre prospective cohort study.
    BMJ Open. 2025;15:e093863.
    PubMed    
    Abstract available

  46. WEHBE S, Gallwas J, Grundker C
    Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells.
    Anticancer Res. 2025;45:1793-1805.
    PubMed    
    Abstract available

  47. SIMONETTI E, Pistolesi S, Ferrari A, Della Rosa M, et al
    Role of Stromal CD25+/CD8+ Lymphocyte Ratio in Patients With Grade 2-3 Cervical Intraepithelial Neoplasia (CIN 2-3): A Retrospective Single-center Study.
    Anticancer Res. 2025;45:2041-2050.
    PubMed    
    Abstract available

  48. MORA DE, Del Campo AV, DE Castro Momioto A, Solano AM, et al
    Colposcopic Alterations Are More Frequent in Smokers and Appear at a Younger Age.
    In Vivo. 2025;39:1453-1457.
    PubMed    
    Abstract available

  49. YUE Y, Mu Z, Wang X, Liu Y, et al
    [Aurora-A overexpression promotes cervical cancer cell invasion and metastasis by activating the NF-kappaBp65/ARPC4 signaling axis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:837-843.
    PubMed    
    Abstract available

  50. HOUVESSOU GM, Saidu R, Boa R, Mbatani N, et al
    Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on Self- and Clinician-Collected Samples in South Africa.
    JCO Glob Oncol. 2025;11:e2500037.
    PubMed    
    Abstract available

  51. DONKOR A, Osei LP, Acquaah-Arhin EAK, Suka PD, et al
    Determinants of cervical cancer knowledge and barriers to human papillomavirus vaccine uptake among female university students: A cross-sectional study.
    Womens Health (Lond). 2025;21:17455057251335446.
    PubMed    
    Abstract available

  52. LOEB AM, Gravitt P, Frank A, Puricelli Perin DM, et al
    Assessing the global implications of the COVID-19 pandemic on the cervical cancer elimination initiative.
    PLOS Glob Public Health. 2025;5:e0004419.
    PubMed    
    Abstract available

  53. MORENO VA, Nogueira DL, Delgado D, Valdez MJ, et al
    Misconceptions and knowledge gaps about HPV, cervical cancer, and HPV vaccination among central American immigrant parents in the United States.
    Hum Vaccin Immunother. 2025;21:2494452.
    PubMed    
    Abstract available

  54. ZHOU XY, Chen MM, Yu JM, Zhou Y, et al
    Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer.
    Open Life Sci. 2025;20:20221052.
    PubMed    
    Abstract available

  55. YU Q, Sun Y, Zhang S, Xu X, et al
    Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy.
    J Inflamm Res. 2025;18:5371-5382.
    PubMed    
    Abstract available

  56. FU Q, Xu Y, Yang X, An J, et al
    An offline adaptive planning method based on delivered accumulated dose for brachytherapy in cervical cancer.
    Clin Transl Radiat Oncol. 2025;53:100964.
    PubMed    
    Abstract available

  57. ALLALI M, Errafii K, Lamsisi M, Fichtali K, et al
    Cervical cancer in Morocco: a literature review on risk factors, prevalence, and healthcare challenges.
    Pan Afr Med J. 2025;50:11.
    PubMed    
    Abstract available

  58. ZHAO Q
    Effect of integrated care model on urinary retention after radical hysterectomy for cervical cancer.
    Pak J Med Sci. 2025;41:963-967.
    PubMed    
    Abstract available

  59. TSOY LV, Kutusheva MO, Barinova IV, Paramonova NB, et al
    [Placenta increta into the scar in combination with high-grade squamous intraepithelial lesion of the cervix].
    Arkh Patol. 2025;87:64-68.
    PubMed    
    Abstract available

  60. DUDUYEMI BM, Addae EK, Bedu-Addo K, Manu EA, et al
    Analysis of the Histopathological Characteristics and Expression of RIPK1 and NF- kappaB in Cervical Cancer in Kumasi, Ghana.
    Niger J Clin Pract. 2025;28:496-501.
    PubMed    
    Abstract available

  61. CONG C, Liu R, Sun Y, Xu H, et al
    A biosensor based on tetrahydroxyborate-bismuth vanadate for early diagnosis towards lncRNA markers in cervical cancer tumors.
    Talanta. 2025;294:128218.
    PubMed    
    Abstract available

  62. LI Q, Cheng Q, Tian D, An Z, et al
    Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 33.
    Virol J. 2025;22:121.
    PubMed    
    Abstract available

  63. CYRIAC J, Jenkins GD, Strelow BA, O' Laughlin DJ, et al
    A cross-sectional analysis of factors associated with cervical cancer screening in a large midwest primary care setting.
    BMC Womens Health. 2025;25:204.
    PubMed    
    Abstract available

  64. ZHANG YQ, Deng XY, Guan P, Zhang ZH, et al
    [Clinical application of transvaginal core needle biopsy for pelvic masses under finger guidance via vagino-recto-abdominal examination].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:297-303.
    PubMed    
    Abstract available


  65. [Multi?disciplinary treatment approach in cervical cancer care: chinese gynecologic oncologists consensus].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:241-259.
    PubMed    


  66. ASHRAFI GH, Ozdogan M, Cakir MO
    Papillomavirus-Induced Oncogenesis: Bridging Molecular Mechanisms, Diagnostics, and Global Prevention Strategies.
    Viruses. 2025;17:515.
    PubMed    
    Abstract available

  67. DE OLIVEIRA MC, de Oliveira JN, Castilha EP, Fortunato GM, et al
    CTLA4 Haplotype Structures and -318 C>T (rs5742909) Genetic Variant Contribute to the Susceptibility of HPV Infection and Cervical Cancer.
    Viruses. 2025;17:453.
    PubMed    
    Abstract available

  68. VRABIE EM, Eftimie MA, Balescu I, Diaconu C, et al
    A Minimally Invasive Treatment Approach for Early-Stage Uterine Cervical Cancer: The Impact of the LACC Trial and a Literature Review.
    Medicina (Kaunas). 2025;61:620.
    PubMed    
    Abstract available

  69. RIPEPI C, Cracco F, Ricci G, Nappi L, et al
    Adjuvant Therapy in "Intermediate-Risk" Early-Stage Cervical Cancer: To Treat or Not to Treat? Systematic Review and Meta-Analysis.
    Cancers (Basel). 2025;17:1320.
    PubMed    
    Abstract available

  70. AYDIN M, Avci IA
    The effect of the music-supported education program on the awareness and health beliefs of Roma women about cervical cancer and screening.
    BMC Public Health. 2025;25:1536.
    PubMed    
    Abstract available

  71. HAMBACH L, Gallwas J, Grundker C
    G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects Aggressiveness of Cervical Carcinoma Cells Depending on Histological Entity.
    Cancer Genomics Proteomics. 2025;22:397-414.
    PubMed    
    Abstract available

  72. HAMBACH L, Gallwas J, Grundker C
    Expression of "Hallmarks of Cancer" Genes in Cervical Carcinoma Is Differentially Affected by GPER1 Overexpression Depending on Histologic Entity.
    Cancer Genomics Proteomics. 2025;22:415-433.
    PubMed    
    Abstract available

  73. DUAN H, Li H, Su Q, Liu P, et al
    Galectin-1-targeted theranostic nanoprobe for multimodal imaging and photothermal therapy in cervical cancer lymph node metastases.
    Colloids Surf B Biointerfaces. 2025;253:114714.
    PubMed    
    Abstract available

  74. GARCIA-ACOSTA JG, Castaneda-Angeles EG
    [Colitis cystica profunda induced by radiation 27 years later. Case report].
    Rev Med Inst Mex Seguro Soc. 2025;63:e6332.
    PubMed    
    Abstract available

  75. VAN NGUYEN H, Nguyen STM, Tran HTT, Truong LTH, et al
    Elemental Composition of Women's Fingernails: A Comparative Analysis Between Cervical Cancer Patients and Healthy Individuals.
    Biol Trace Elem Res. 2025 Apr 25. doi: 10.1007/s12011-025-04628.
    PubMed    
    Abstract available

  76. MEDICI F, Ferioli M, Zamfir AA, Buwenge M, et al
    Integrating Novel and Classical Prognostic Factors in Locally Advanced Cervical Cancer: A Machine Learning-Based Predictive Model (ESTHER Study).
    J Pers Med. 2025;15:153.
    PubMed    
    Abstract available

  77. FENG D, Yao Y, Zhu X, Chen J, et al
    Human papillomavirus (HPV) infection and liquid-based cytologic tests among cervical screening participants in Shannan City, Tibet, China, during 2021-2022.
    BMC Infect Dis. 2025;25:599.
    PubMed    
    Abstract available

  78. PAYTON C, Kvaratskhelia N, Chalfin M, Deffler J, et al
    Cervical, Breast, and Colorectal Cancer Screening Outcomes Among Refugees in Philadelphia, Pennsylvania.
    J Immigr Minor Health. 2025;27:480-488.
    PubMed    
    Abstract available

  79. AMIRI S, Petras A, Buchwald D
    Persistent Effect of Redlining on Survival from Screenable Cancers in Washington State, 2000-2018.
    J Urban Health. 2025;102:290-304.
    PubMed    
    Abstract available

  80. KEAM SJ
    Iparomlimab and Tuvonralimab: First Approval.
    Drugs. 2025;85:699-706.
    PubMed    
    Abstract available

  81. VAN KEER S, Latsuzbaia A, Vanden Broeck D, De Sutter P, et al
    Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples.
    J Mol Diagn. 2025;27:419-429.
    PubMed    
    Abstract available

  82. SOUSA R, Fonseca-Moutinho JA, Gomes F, Loureiro F, et al
    Spatial analysis of HPV infection and contextual factors associated with higher HPV prevalence.
    Ann Epidemiol. 2025;105:8-14.
    PubMed    
    Abstract available

  83. HENDERSON M, Lyons D, Beddows S, Cowen M, et al
    High-risk human papillomavirus prevalence and serostatus in a cohort of cisgender women and people with a cervix living with perinatally acquired HIV.
    HIV Med. 2025 Feb 25. doi: 10.1111/hiv.70001.
    PubMed    
    Abstract available

  84. GE J, Xu X
    The Expression of Programmed Cell Death Ligand-1 and its Relationship with Infiltration, Metastasis and Prognosis in Cervical Squamous Cell Carcinoma.
    Reprod Sci. 2025;32:1676-1684.
    PubMed    
    Abstract available

  85. ATLAS SJ, Gallagher KL, McGovern SE, Wint AJ, et al
    Patient Perceptions on the Follow-Up of Abnormal Cancer Screening Test Results.
    J Gen Intern Med. 2025;40:1280-1287.
    PubMed    
    Abstract available

  86. HAN Y, Shi L, Jiang N, Huang J, et al
    Dissecting the Single-Cell Diversity and Heterogeneity Underlying Cervical Precancerous Lesions and Cancer Tissues.
    Reprod Sci. 2025;32:1502-1519.
    PubMed    
    Abstract available

  87. CAO L
    Multiple Lines of Treatment in a Patient with Small Cell Neuroendocrine Carcinoma of the Cervix: A Case Report.
    Ann Clin Lab Sci. 2025;55:286-292.
    PubMed    
    Abstract available

  88. WANG S, Liu C, Ye D, Qi J, et al
    Deciphering the mechanism of baicalein in cervical cancer via bioinformatics, machine learning and computational simulations: PIM1 and CDK2 are key target proteins.
    Int J Biol Macromol. 2025 May 6:144014. doi: 10.1016/j.ijbiomac.2025.144014.
    PubMed    
    Abstract available

  89. GU D, Liang X, Shao Z, He H, et al
    A cascaded amplification carrier-free nanoplatform for synergistic photothermal/ferroptosis therapy via dual antioxidant pathway disruption in cervical cancer.
    J Mater Chem B. 2025 May 8. doi: 10.1039/d5tb00627.
    PubMed    
    Abstract available

  90. XUE S, Zeng X, Li J, Kang L, et al
    Feasibility and acceptability of human papillomavirus self-sampling compared with clinician sampling in urban areas of western China: a cross-sectional survey.
    Front Public Health. 2025;13:1524796.
    PubMed    
    Abstract available

  91. TOKALIOGLU AA, Oktar O, Aytekin O, Alci A, et al
    Intermediate?risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapy.
    Oncol Lett. 2025;29:308.
    PubMed    
    Abstract available

  92. BRAVO E, Cartagena J, Urbina C, Galdames L, et al
    Vaginal radical hysterectomy in early stage cervical cancer.
    Gynecol Oncol Rep. 2025;59:101744.
    PubMed    
    Abstract available

  93. SUN X, Chen Z, Yang H, Yu J, et al
    Targeting ferroptosis for precision medicine in cervical cancer.
    Apoptosis. 2025 May 7. doi: 10.1007/s10495-025-02120.
    PubMed    
    Abstract available

  94. XIANG H, Sun J, Kong L, Wang Y, et al
    NDUFA8 promotes cell viability and inhibits ferroptosis and cisplatin sensitivity by stabilizing Fe-S clusters in cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2025 May 8. doi: 10.1007/s00210-025-04237.
    PubMed    
    Abstract available

  95. SU S, Yang B, Liu H, Yin W, et al
    Four genes shared between rheumatoid arthritis and cervical cancer are associated with cervical cancer prognosis.
    Sci Rep. 2025;15:15884.
    PubMed    
    Abstract available

  96. LI J, Wu T, Cai M, Xie C, et al
    Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer: a multicenter real-world study.
    Sci Rep. 2025;15:15877.
    PubMed    
    Abstract available

  97. CHOI H, Dion H, Huang M, Sathyan L, et al
    Applying the Information-Motivation-Behavioral Skills model to a video-assisted HPV intervention to promote self-screening uptake: a qualitative study in Western Kenya.
    BMJ Glob Health. 2025;10:e017616.
    PubMed    
    Abstract available

  98. DE SOUZA LEAO LQ, de Andrade JC, Marques GM, Guimaraes CC, et al
    Rapid prediction of cervical cancer and high-grade precursor lesions: An integrated approach using low-field (1)H NMR and chemometric analysis.
    Clin Chim Acta. 2025;574:120346.
    PubMed    
    Abstract available

  99. LI Y, Liu T, Pan G, Li Y, et al
    Orychophragvioline A, a Novel Alkaloid Isolated from Orychophragmus violaceus with Anti-Cervical Cancer Activity.
    Molecules. 2025;30:1759.
    PubMed    
    Abstract available

  100. OLIVIERI DJ, Eastment MC, Mugisha N, Menon MP, et al
    Correlates of cervical cancer awareness among women aged 30-49 in five sub-Saharan African nations: Evidence from the Demographic and Health Survey (DHS)-2017-2023.
    PLOS Glob Public Health. 2025;5:e0003344.
    PubMed    
    Abstract available

  101. FREIRE GS, Amaral CLR, Romano JJ, Bussamra Aulicino C, et al
    Human papillomavirus vaccination: if the vaccine is important and available, why not use it?
    Rev Assoc Med Bras (1992). 2025;71:e20240865.
    PubMed    
    Abstract available

  102. WANG W, Zhang Y
    Analysis of the Predictive Efficacy and Influencing Factors of Serum Tie-1, FoxO3a, and PKD1 for Lymph Node Metastasis in Cervical Cancer.
    Int J Womens Health. 2025;17:1215-1224.
    PubMed    
    Abstract available

  103. SITTIWONG W, Dankulchai P, Wongsuwan P, Prasartseree T, et al
    Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives.
    Clin Transl Radiat Oncol. 2025;53:100965.
    PubMed    
    Abstract available

  104. LI X, Deng J, Liu X, Zhou Y, et al
    Tissue-resident immune cells in cervical cancer: emerging roles and therapeutic implications.
    Front Immunol. 2025;16:1541950.
    PubMed    
    Abstract available

  105. CHEN G, Zheng Z, Ji Q, He R, et al
    Tumor innervation in cervical cancer: Prognostic insights from myelin-associated risk signatures.
    FASEB Bioadv. 2025;7:e70004.
    PubMed    
    Abstract available

  106. GRIESMER K, Hadderton L, Bishop LR, Robinett DA, et al
    A Case of Hemorrhagic Shock From Newly Diagnosed Cervical Cancer.
    Cureus. 2025;17:e81793.
    PubMed    
    Abstract available

  107. ALDARIZ-AMAYA R, Rodriguez-Esquivel M, Ruiz-Romero A, Anthor F, et al
    Innovative Noninvasive HPV Screening Using a Feminine Pad: A Pilot Study for Enhanced Cervical Cancer Detection.
    Obstet Gynecol Int. 2025;2025:9344596.
    PubMed    
    Abstract available

  108. BURROWES S, Seyoum Alemu H, Khokhar N, McMillian G, et al
    Coordinating under constraint: a qualitative study of communication and teamwork along Ethiopia's cervical cancer care continuum.
    BMC Health Serv Res. 2025;25:652.
    PubMed    
    Abstract available

  109. XU H, Li S, Luo X, Zhou Z, et al
    [Oncolytic virus-mediated base editing for targeted killing of cervical cancer cells].
    Sheng Wu Gong Cheng Xue Bao. 2025;41:1382-1394.
    PubMed    
    Abstract available

  110. ZHOU Q, Li T, Zhu L, Chang Y, et al
    The clinical performance of different cervical cancer screening strategies in premenopausal and postmenopausal women.
    Menopause. 2025 May 6. doi: 10.1097/GME.0000000000002546.
    PubMed    
    Abstract available

  111. EKWUEME DU, Reagan KA, Kao SY, Dasari S, et al
    Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity.
    Cancer Causes Control. 2025 May 6. doi: 10.1007/s10552-025-02006.
    PubMed    
    Abstract available

  112. ZHENG J, Feng Y, Yuan C
    Hsa_circ_0007905 as a modulator of miR-330-5p and VDAC1: Enhancing stemness and reducing apoptosis in cervical cancer stem cells.
    Gen Physiol Biophys. 2025;44:213-226.
    PubMed    
    Abstract available

  113. NESSA A, Uddin SMN, Lucas E, Nag P, et al
    Implementation of an electronic health information system using DHIS2 tracker to manage and evaluate the National cervical screening programme in Bangladesh.
    BMC Public Health. 2025;25:1649.
    PubMed    
    Abstract available

  114. CERQUEIRA L, Pinto PV, Bernardes J, Martinho M, et al
    Vaginal myomectomy of multiple cervical myomas.
    BMJ Case Rep. 2025;18:e264879.
    PubMed    
    Abstract available

  115. HUANG CS, Hsiao BY, Wu MH, Chiang CJ, et al
    Association Between Screening History and Prognosis of Cervical Carcinoma in Situ and Invasive Cervical Cancer: A Population-Based Cohort Study.
    Ann Epidemiol. 2025 May 3:S1047-2797(25)00089.
    PubMed    
    Abstract available

  116. LAVECCHIA M, Selk A, Marcucci M, Nica A, et al
    Lifetime Cervical Cancer Screening and Social Determinants of Health in the Canadian Longitudinal Study on Aging.
    J Low Genit Tract Dis. 2025 May 2. doi: 10.1097/LGT.0000000000000895.
    PubMed    
    Abstract available

  117. NANDI A, Ghosh A, Sil SK
    The interplay between angiogenesis and cervical cancer: a comprehensive review.
    Expert Rev Anticancer Ther. 2025 May 5. doi: 10.1080/14737140.2025.2501073.
    PubMed    
    Abstract available

  118. ZHANG YY, Li M, Xu YD, Shang J, et al
    Retraction Note: LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.
    Eur Rev Med Pharmacol Sci. 2025;29:151.
    PubMed    
    Abstract available

  119. AGHA S, Zeng W
    Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh.
    Hum Vaccin Immunother. 2025;21:2500264.
    PubMed    
    Abstract available

  120. WU X, Xu C, Zhang X, Qu Q, et al
    Preoperative prediction of p16 expression in cervical cancer by amide proton transfer imaging combined with diffusion kurtosis imaging: a retrospective study.
    PeerJ. 2025;13:e19387.
    PubMed    
    Abstract available

  121. RAGHANI NR, Chorawala MR, Parekh K, Sharma A, et al
    Exosomal miRNA-based theranostics in cervical cancer: bridging diagnostics and therapy.
    Med Oncol. 2025;42:193.
    PubMed    
    Abstract available

  122. ESWARAN S, Mascarenhas R, Kabekkodu SP
    The ester derivative Palmitoylcarnitine abrogates cervical cancer cell survival by enhancing lipotoxicity and mitochondrial dysfunction.
    Cell Commun Signal. 2025;23:213.
    PubMed    
    Abstract available

  123. ZHAO L, Chen X, Zhang Y, Cen Y, et al
    The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical carcinogenesis.
    J Transl Med. 2025;23:506.
    PubMed    
    Abstract available

  124. ZHU F, Li L, Zhang H, Liu J, et al
    Dynamic causal effects of gut microbiota on cervical Cancer lesion progression.
    Sci Rep. 2025;15:15490.
    PubMed    
    Abstract available

  125. MAI Q, Du Q, Zeng F, Chen Y, et al
    Galectin-3 suppresses CD8(+) T cells function via myeloid-derived suppressor cells recruitment in cervical cancer.
    Int J Biol Macromol. 2025 May 1:143683. doi: 10.1016/j.ijbiomac.2025.143683.
    PubMed    
    Abstract available

  126. GOMES MLS, Cestari VRF, Florencio RS, Yamamura M, et al
    Spatial-temporal analysis of cervical cancer screening and social and health indicators in Brazil.
    Public Health. 2025;243:105747.
    PubMed    
    Abstract available

  127. KANG Y, Chang L, Liu J, Ji H, et al
    Prognostic Differences and Survival Predictive Models for Mucinous Versus Usual-Type Adenocarcinoma of the Uterine Cervix.
    Cancer Med. 2025;14:e70927.
    PubMed    
    Abstract available

  128. RAGUPATHY K, McMullen W
    Cervical cancer prevention - interventions to improve screening.
    Scott Med J. 2025;70:25-26.
    PubMed    


  129. ZHENG Z, Liu D, Su Y
    Supine/prone position fixation treatment in cervical cancer radiotherapy.
    J Cancer Res Ther. 2025;21:401-408.
    PubMed    
    Abstract available

  130. KE X, Zang C, Wu A, Liu Y, et al
    Predicting the incidence of hematologic toxicity in concurrent chemoradiotherapy for cervical cancer using pelvic MRI imaging.
    J Cancer Res Ther. 2025;21:354-361.
    PubMed    
    Abstract available

  131. MISHRA SK, Shaheen MM, Sultana S, Al-Dies AM, et al
    Computational analysis of lupenone derivatives as potential inhibitor of human papillomavirus oncoprotein E6 associated cervical cancer.
    Sci Rep. 2025;15:15402.
    PubMed    
    Abstract available

  132. CHE Y, Song B, Song Y, Sun J, et al
    Thymoquinone enhances efficacy of cervical Cancer therapeutic vaccines via modulating CD8(+) T cells.
    Int Immunopharmacol. 2025 Apr 9:114605. doi: 10.1016/j.intimp.2025.114605.
    PubMed    
    Abstract available

  133. GANESH GV, Balu G, Jayasuriya R, Ramkumar KM, et al
    Exosomal miR16 Induced by Allyl Isothiocyanate (AITC) Inhibits Tumor Growth in Cervical Cancer via Modulation of Apoptotic and Inflammatory Pathways.
    Arch Biochem Biophys. 2025 Apr 30:110446. doi: 10.1016/j.abb.2025.110446.
    PubMed    
    Abstract available

  134. SHIBATA T, Ohno A, Murakami I, Takakura M, et al
    Effect of chemical peeling therapy for treatment of cervical intraepithelial neoplasia on cervicovaginal microbiota.
    J Appl Microbiol. 2025;136:lxaf080.
    PubMed    
    Abstract available

  135. LENOIR P, Guillet J, Desmarets M, Baraquin A, et al
    Human papillomavirus genotype distribution among high-grade cervical lesions in French women born between 1972 and 1993.
    J Gynecol Obstet Hum Reprod. 2025;54:102945.
    PubMed    
    Abstract available

  136. SIDDIQI KZ, Baandrup L, Diederichsen L, Hertzum-Larsen R, et al
    Risk of HPV-associated precancer and cancer in women with systemic lupus erythematosus.
    Ann Rheum Dis. 2025;84:760-766.
    PubMed    
    Abstract available

  137. WHEELER CM, Adcock R, Hunt WC, Robertson M, et al
    HPV genotype-specific prevalence and infection risks: A 10-year population-based study from the United States.
    J Natl Cancer Inst. 2024 Dec 10:djae327. doi: 10.1093.
    PubMed    
    Abstract available

  138. HIMOTO Y, Kido A, Yamanoi K, Kurata Y, et al
    Limited diagnostic performance of imaging evaluation for staging in gastric-type endocervical adenocarcinoma: a multi-center study.
    Jpn J Radiol. 2025;43:810-819.
    PubMed    
    Abstract available

  139. RING LL, Lindquist S, Rosthoj S, Larsen HK, et al
    Prevalence of cervical human papillomavirus in kidney transplant recipients: A systematic review and meta-analysis.
    Prev Med. 2024;182:107927.
    PubMed    
    Abstract available

  140. DENG J, Li Y, Zhang L, Liao W, et al
    Piezo1 regulates actin cytoskeleton remodeling to drive EMT in cervical cancer through the RhoA/ROCK1/PIP2 signaling pathway.
    Discov Oncol. 2025;16:787.
    PubMed    
    Abstract available

  141. LYAMUYA T, Mchome B, Stroetmann CY, Machange R, et al
    Barriers to adherence to cervical cancer screening care in Northern Tanzania.
    Oncologist. 2025;30:oyaf111.
    PubMed    
    Abstract available

  142. HENRY M, Ngwegya T, Lekena N, Barth S, et al
    In vitro anti-tumour activities of a novel recombinant immunotoxin targeting differentially overexpressed Leucine-rich repeat-containing G-protein-coupled receptor 5 in cervical cancer.
    Immunopharmacol Immunotoxicol. 2025.
    PubMed    
    Abstract available

  143. VEGVARY Z, Koszo R, Egyud Z, Varga L, et al
    MRI-based image-guided adaptive brachytherapy for locally advanced cervical cancer in clinical routine: a single-institution experience.
    Pathol Oncol Res. 2025;31:1612077.
    PubMed    
    Abstract available

  144. LANG J, Liu Q, Ji R, Qiu M, et al
    Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemotherapy followed by radiotherapy with maintenance therapy: a case repor
    Front Immunol. 2025;16:1573202.
    PubMed    
    Abstract available

  145. WANG H, Liu Y, Xu HF, Chen PP, et al
    [Evaluation of high-risk HPV genotyping detection in cervical cancer screening based on a prospective cohort study].
    Zhonghua Zhong Liu Za Zhi. 2025;47:435-442.
    PubMed    
    Abstract available

  146. HAN H, Zhou H, He J, Zhang X, et al
    An Explainable Deep Learning Framework for Predicting Postoperative Radiotherapy-Induced Vaginal Stenosis in Surgically Treated Cervical Cancer Patients.
    Ann Ital Chir. 2025;96:602-616.
    PubMed    
    Abstract available

  147. WEI S, Hu A, Liang Y, Yang J, et al
    Feasibility study of automatic radiotherapy treatment planning for cervical cancer using a large language model.
    Radiat Oncol. 2025;20:77.
    PubMed    
    Abstract available

  148. ZHANG C, Jiang H, Yuan L, Liao Y, et al
    Correction: CircVPRBP inhibits nodal metastasis of cervical cancer by impeding RACK1 O-GlcNAcylation and stability.
    Oncogene. 2025 May 15. doi: 10.1038/s41388-025-03440.
    PubMed    


  149. YE ZC, Lu Q, Xue P, Jiang Y, et al
    [A Meta-analysis of the application of artificial intelligence in cervical cytopathology diagnosis].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:572-580.
    PubMed    
    Abstract available

  150. TARNEY CM, Tian C, Randall LM, Hussain SA, et al
    Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical Hysterectomy.
    JAMA Netw Open. 2025;8:e2510717.
    PubMed    
    Abstract available

  151. GARDNER UG, Viswanathan AN
    Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy.
    Curr Treat Options Oncol. 2025 May 15. doi: 10.1007/s11864-025-01325.
    PubMed    
    Abstract available

  152. MARKERS D
    RETRACTION: The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.
    Dis Markers. 2025;2025:9817180.
    PubMed    
    Abstract available

  153. KUANG H, Yang D, Lin R, Tang Y, et al
    A Nomogram Based on Fibrinogen-to-Neutrophil Ratio as a Novel Predictor of Lymph Node Metastasis in Patients with Cervical Cancer and Type 2 Diabetes Mellitus.
    Cancer Manag Res. 2025;17:933-954.
    PubMed    
    Abstract available

  154. CHENG X, Wang P, Cheng L, Zhao F, et al
    Trends in cervical cancer incidence and mortality in the United States, 1975-2018: a population-based study.
    Front Med (Lausanne). 2025;12:1579446.
    PubMed    
    Abstract available

  155. LYU G, Li J, Li D
    KLHL17 as a Prognostic Indicator and Therapeutic Target in Cervical Cancer: A Comprehensive Analysis.
    Comb Chem High Throughput Screen. 2025.
    PubMed    
    Abstract available

  156. ZHOU D, Zhang D, Wang Y, Zhou K, et al
    Optimizing strategy for cervical cancer prevention in china: a comprehensive modeling analysis.
    Cost Eff Resour Alloc. 2025;23:20.
    PubMed    
    Abstract available

  157. ZHU T, Chen Z, Zhang B, Wu X, et al
    Prognostic value of platelet to lymphocyte ratio in patients with cervical cancer: an updated systematic review and meta-analysis.
    World J Surg Oncol. 2025;23:187.
    PubMed    
    Abstract available

  158. TANG WZ, Cai QY, Huang KJ, Xu WZ, et al
    The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021.
    BMC Public Health. 2025;25:1774.
    PubMed    
    Abstract available

  159. WANG F, Liu Y, Jia J, Bai X, et al
    Causality between 22 personal traits and cervical cancer: a two-sample Mendelian randomization study.
    J Affect Disord. 2025 May 12:S0165-0327(25)00780.
    PubMed    
    Abstract available

  160. SSEDYABANE F, Niyonzima N, Ngonzi J, Najjuma JN, et al
    Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western Uganda: A Case-Control Study.
    Anal Cell Pathol (Amst). 2025;2025:1931921.
    PubMed    
    Abstract available

  161. ZHANG Y, Rong L, Jiang H, Mu X, et al
    Construction and validation of nomograms for predicting overall survival and cause-specific survival in cervical cancer patients undergoing radical radiotherapy based on the SEER database.
    Front Med (Lausanne). 2025;12:1587465.
    PubMed    
    Abstract available

  162. FALUDI VARGANE E, Ghanem AS, Nguyen CM, Pataki J, et al
    Influencing factors on attendance in cervical cancer screening among women with diabetes in Hungary: a cross-sectional study using European Health Interview Surveys 2009-2019.
    Front Oncol. 2025;15:1501654.
    PubMed    
    Abstract available

  163. PUNTAMBEKAR S, Parulekar M, Venkateswaran S, Naidu S, et al
    Comparative Outcomes of Laparoscopic Radical Hysterectomy and Nerve-Sparing Technique in Cervical Cancer Patients.
    JSLS. 2025;29:e2024.
    PubMed    
    Abstract available

  164. YAO S, Chen S, Wang A, Liang Z, et al
    BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING.
    Adv Sci (Weinh). 2025 May 14:e70005. doi: 10.1002/advs.202414637.
    PubMed    
    Abstract available

  165. AKAN A, Omo-Aghoja L, Adeyinka A
    The Diagnostic Performance of Pap Smear during Both Phases of the Menstrual Cycle: A Community-based Study in Southern Nigeria.
    Niger Postgrad Med J. 2025;32:120-126.
    PubMed    
    Abstract available

  166. RAZA MA, Siddiqui HUR, Saleem AA, Zafar K, et al
    Advanced Feature Extraction for Cervical Cancer Image Classification: Integrating Neural Feature Extraction and AutoInt Models.
    Sensors (Basel). 2025;25:2826.
    PubMed    
    Abstract available

  167. HONG MK, Wang JH, Li MH, Su CC, et al
    Topological Distribution of the Sex Hormone Receptor Expressions Highlights the Importance of Stromal ERalpha and Epithelial PR in Malignant Transformation of the Uterine Cervix.
    Int J Mol Sci. 2025;26:4418.
    PubMed    
    Abstract available

  168. WEN H, Zhang Y, Liu Y, Long H, et al
    The Significance of Circulating Microbial Signatures in the Prognosis and Immune Microenvironment of Patients with Cervical Cancer.
    Int J Mol Sci. 2025;26:4293.
    PubMed    
    Abstract available

  169. PASZTOR R, Viskolcz B, Olah C, Varadi C, et al
    Comparative Analysis of Serum N-Glycosylation in Endometriosis and Gynecologic Cancers.
    Int J Mol Sci. 2025;26:4105.
    PubMed    
    Abstract available

  170. ZHOU E, Bhoora S, Pillay TS, Punchoo R, et al
    Induction of Cell Death and Regulation of Autocrine Vitamin D Metabolism in Cervical Cancer by Physiological and GI20 Doses of 25-Hydroxycholecalciferol.
    Int J Mol Sci. 2025;26:4008.
    PubMed    
    Abstract available

  171. SCHELLEKENS HCJ, Schmidt LMS, Morre SA, van Esch EMG, et al
    Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review.
    Int J Mol Sci. 2025;26:3954.
    PubMed    
    Abstract available

  172. GOMES M, Provaggi E, Pembe AB, Olaitan A, et al
    Advancing Cervical Cancer Prevention Equity: Innovations in Self-Sampling and Digital Health Technologies Across Healthcare Settings.
    Diagnostics (Basel). 2025;15:1176.
    PubMed    
    Abstract available

  173. MUALLEM MZ, Sayasneh A
    Debunking Myths and Misinformation in Cervical Cancer: A Narrative Review on Navigating Complex Treatment Choices in Locally Advanced Cases and Exploring Beyond Standard Protocols.
    Diagnostics (Basel). 2025;15:1174.
    PubMed    
    Abstract available

  174. ZHOU SH, He YQ, Diao H, Yang DW, et al
    Mediation of Ethnic Disparity in the 5-Year Mortality of Cervical Cancer Patients in the US, 2001-2019.
    Healthcare (Basel). 2025;13:964.
    PubMed    
    Abstract available

  175. BARTOSZEWSKA E, Czapla M, Rakoczy K, Filipski M, et al
    The Role of Ion Channels in Cervical Cancer Progression: From Molecular Biomarkers to Diagnostic and Therapeutic Innovations.
    Cancers (Basel). 2025;17:1538.
    PubMed    
    Abstract available

  176. JIA SZ, Yang D, Yang XJ, Wang R, et al
    Risk stratification of node-positive early-stage cervical cancer treated with radical hysterectomy followed by chemoradiotherapy: a retrospective single-center study.
    Radiat Oncol. 2025;20:73.
    PubMed    
    Abstract available

  177. SUN M, Xu B, Yu J, Wu Y, et al
    Outcomes following conization and factors on HPV regression among young females in Wuxi.
    BMC Womens Health. 2025;25:223.
    PubMed    
    Abstract available

  178. WANG H, Jin P
    Risk stratification and conservative management of women aged 25-40 years with cervical intraepithelial neoplasia grade 2(CIN2).
    BMC Infect Dis. 2025;25:696.
    PubMed    
    Abstract available

  179. DILLNER J, Gray P
    [HPV screening coverage and cancer].
    Lakartidningen. 2025;122:25007.
    PubMed    
    Abstract available

  180. MOSALO A, Maree JE
    Supporting women undergoing radiotherapy for cervical cancer: A pilot intervention.
    Health SA. 2025;30:2815.
    PubMed    
    Abstract available

  181. GUO P, Wu L, Wang H, Wang L, et al
    The Relationship between Systemic Expression Levels of Immune Cells and Tumor Markers and High-Risk HPV Infection in Patients with Cervical Cancer, Cervical Intraepithelial Neoplasia, and Chronic Cervicitis, and its Clinical Significance.
    Int J Womens Health. 2025;17:1263-1270.
    PubMed    
    Abstract available

  182. GAO YY, Li XX, Zuo H, Zhang P, et al
    Analysis of the Relationship Between Cervical Cancer Progression and the Microbiome.
    Int J Gen Med. 2025;18:2449-2460.
    PubMed    
    Abstract available

  183. CHAO CR, Cannizzaro N, Hahn EE, Shen E, et al
    A pragmatic randomized trial to compare strategies for implementing primary HPV testing for routine cervical cancer screening in a large healthcare system.
    Implement Sci. 2025;20:21.
    PubMed    
    Abstract available

  184. GAO Z, Yin Z, Sun L, Zhao H, et al
    Comparison of oncological outcomes between radical hysterectomy and radiochemotherapy for International Federation of Gynecology and Obstetrics 2018 stage IIIC1 cervical adenocarcinoma: A retrospective multicenter cohort study.
    J Obstet Gynaecol Res. 2025;51:e16307.
    PubMed    
    Abstract available

  185. KE X, Li L, Yan Q, Wang X, et al
    EGFR/STAT3 signaling mediates the upregulation of CD47 in HPV-positive cervical cancer by activating p65 and exosome transporter RAB31.
    Neoplasma. 2025;72.
    PubMed    
    Abstract available

  186. PARVEEN S, Ahtsham A, Kumar S, Gupta P, et al
    Piperlongumine mediated apoptosis in cervical cancer cells beyond docking predictions.
    Toxicol Rep. 2025;14:102031.
    PubMed    
    Abstract available

  187. WANG W, Huang C, Bi S, Liang H, et al
    A predictive model for the transformation from cervical inflammation to cancer based on tumor immune-related factors.
    Front Immunol. 2025;16:1532048.
    PubMed    
    Abstract available

  188. MUHETAER G, He X, Yang C, Guo F, et al
    Single-cell combined transcriptome probes prognostic mechanisms of sialylation-related genes in cervical cancer.
    Front Oncol. 2025;15:1534247.
    PubMed    
    Abstract available

  189. OKUNOWO AA, Anumni CC, Habeebu MY, Olayioye OM, et al
    Reproductive and Sexual Predictors of Late-Stage Cervical Cancer Presentation in Lagos, Nigeria.
    Cureus. 2025;17:e81934.
    PubMed    
    Abstract available

  190. AUGUST C, Barroeta JE, Conant JL, Paintal RD, et al
    Using See, Test & Treat(R) to Increase Uptake of Breast and Cervical Cancer Screenings: Report from the Field.
    J Health Care Poor Underserved. 2025;36:757-764.
    PubMed    
    Abstract available

  191. HONG DD, Shang TT, Guo HY, Zuo WT, et al
    [Role of Toll-like receptors in persistent infection of cervical high-risk human papillomavirus based on "latent pathogen theory"].
    Zhongguo Zhong Yao Za Zhi. 2025;50:1974-1979.
    PubMed    
    Abstract available

  192. BARTL T, Dorittke T, Ciocsirescu C, Knoth J, et al
    Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy.
    J Gynecol Oncol. 2025 Apr 24. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  193. NEWADKAR ND, Khandeparkar SGS, Gogate BP, Gotekar A, et al
    Immunohistochemical Study of Cyclin D1 and HER2/neu in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix.
    Gulf J Oncolog. 2024;1:14-23.
    PubMed    
    Abstract available

  194. CELEBIC A, Jakimovska Stefanovska M, Miladinovic M, Calleja-Agius J, et al
    Evaluating the role of robotic surgery in gynecological cancer treatment.
    Eur J Surg Oncol. 2025;51:109630.
    PubMed    
    Abstract available

  195. CARUSO G, Gaiano M, De Vitis LA, Stefani E, et al
    Predictors of recurrence in early-stage cervical cancer without adjuvant treatment after radical surgery.
    Eur J Surg Oncol. 2025;51:110121.
    PubMed    
    Abstract available

  196. MAXOVA K, Rehackova M, Jirkovska M, Robova H, et al
    Postoperative quality of life in patients with early-stage cervical cancer: A prospective 10-year follow-up study.
    Eur J Surg Oncol. 2025;51:110119.
    PubMed    
    Abstract available

  197. BULA AK, Mhango P, Tsidya M, Chimwaza W, et al
    Client perspectives and satisfaction with integrating facility and community-based HPV self-sampling for cervical cancer screening with family planning: a mixed method study.
    BMC Public Health. 2025;25:1718.
    PubMed    
    Abstract available

  198. GROVER S, Moorkanat GG, Ketlametswe R, Monare B, et al
    Impact of the COVID-19 Pandemic on Cervical Cancer Treatment Delays in Botswana.
    JCO Glob Oncol. 2025;11:e2400300.
    PubMed    
    Abstract available

  199. ISEME-ONDIEK R, Abuodha J, Ngugi A, Abayo I, et al
    Insights Into Cancer Awareness and Health Practices in Rural Kenya: A Cross-Sectional Study of Esophageal, Breast, Prostate, Cervical, and Colorectal Cancers.
    JCO Glob Oncol. 2025;11:e2400421.
    PubMed    
    Abstract available

  200. ISLAM MF, Nessa A, Zaki QA, Akbar Ashrafi SA, et al
    Evaluation of the National cervical cancer surveillance program in Bangladesh: Performance, strengths, and opportunities for improvement.
    PLOS Glob Public Health. 2025;5:e0004595.
    PubMed    
    Abstract available

  201. CHEN Y, Jiang H, Pang W, Diao Z, et al
    Multi-Task Collaborative Assisted Training Method for Grouping Fuzzy Categories Classification of Cervical Cancer Cells.
    IEEE J Biomed Health Inform. 2025;PP.
    PubMed    
    Abstract available

  202. YU J, Zhang Y
    Mendelian randomization analysis of immune cell traits and their association with cervical cancer risk.
    Discov Oncol. 2025;16:709.
    PubMed    
    Abstract available

  203. GROVER S, Bhatia R, Zhang S, Khan S, et al
    Cervical cancer treatment outcomes and survival in Botswana by HIV status: Ipabalele study results.
    JNCI Cancer Spectr. 2025 May 8:pkaf045. doi: 10.1093.
    PubMed    
    Abstract available

  204. HARIPRASAD R, Srinivasan M, Ravi P, Tamang H, et al
    A qualitative study on ASHA workers' perspective on HPV self-sampling in Sikkim India.
    Sci Rep. 2025;15:15985.
    PubMed    
    Abstract available

  205. MILANOVA V, Gomes M, Mihaylova K, Twelves JL, et al
    Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study.
    J Clin Microbiol. 2025 Apr 11:e0185224. doi: 10.1128/jcm.01852.
    PubMed    
    Abstract available

  206. XIE F, Du K, Li J, Zhong S, et al
    Head-to-head immunogenicity comparison of one-dose Cecolin and Gardasil in Chinese girls aged 9-14 years: A randomized and open-label clinical trial.
    Vaccine. 2025;55:127015.
    PubMed    
    Abstract available

  207. CELEBIC A, Miladinovic M, Jakimovska Stefanovska M, Calleja-Agius J, et al
    Sentinel lymph node biopsy in gynecological malignancies: A modern approach to surgical staging - A narrative review.
    Eur J Surg Oncol. 2025;51:109757.
    PubMed    
    Abstract available

  208. ZHANG R, Hou F, Gan J, Zhang L, et al
    Metformin-induced E6/E7 inhibition prevents HPV-positive cancer progression through p53 reactivation.
    Anticancer Drugs. 2025;36:468-477.
    PubMed    
    Abstract available

  209. YUILL S, Hall MT, Caruana M, Lui G, et al
    Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010-2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening.
    Vaccine. 2025;54:126986.
    PubMed    
    Abstract available

  210. KABARAMBI A, Kizito S, Hunleth J, Silver MI, et al
    HPV Vaccine Uptake and its Predictors among Adolescent Girls and Young Women Living with HIV-in Central Uganda.
    AIDS Behav. 2025;29:1859-1865.
    PubMed    
    Abstract available

  211. CELEBIC A, Harasani K, Miladinovic M, Mandic A, et al
    Neuroendocrine tumors of the gynecological tract: A narrative literature review.
    Eur J Surg Oncol. 2025;51:109735.
    PubMed    
    Abstract available

  212. STOKES MJ, Ramirez PR, Spencer NM, Nelson EL, et al
    Human Papillomavirus Infections and Sequela in Women.
    Clin Obstet Gynecol. 2025;68:188-193.
    PubMed    
    Abstract available

  213. LYCKE KD, Steben M, Garland SM, Woo YL, et al
    An updated understanding of the natural history of cervical human papillomavirus infection-clinical implications.
    Am J Obstet Gynecol. 2025;232:453-460.
    PubMed    
    Abstract available

  214. IDLAHCEN F, Mboukou PFC, Idri A, El Attar H, et al
    PathoCoder: Rethinking the Flaws of Patch-Based Learning for Multi-Class Classification in Computational Pathology.
    Microsc Res Tech. 2025;88:1712-1726.
    PubMed    
    Abstract available

  215. SOLAK B, Arslan M
    Evaluation of HPV and Related Cancer Awareness and Vaccination Attitudes Among Patients with Anogenital Warts: a Survey-Based Study.
    J Community Health. 2025;50:560-567.
    PubMed    
    Abstract available

  216. KARTHIKEYAN N, Chandrasekaran G, Sudha S
    CERVIXNET: An Efficient Approach for the Detection and Classifications of the Cervigram Images Using Modified Deep Learning Architecture.
    Curr Med Imaging. 2025;21:e15734056343690.
    PubMed    
    Abstract available

  217. ADEGBOYEGA A, Leshi O, Obielodan O, Wiggins AT, et al
    Association of Cancer Risk Perception and Patient-provider Communication with Pap Test Among African American and Sub-Saharan African-born Women.
    J Community Health. 2025;50:434-441.
    PubMed    
    Abstract available

  218. KANBERGS A, Clapp M, Wu CF, Melamed A, et al
    Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity.
    Am J Obstet Gynecol. 2024 Oct 22:S0002-9378(24)01083.
    PubMed    
    Abstract available

  219. DI FIORE R, Drago-Ferrante R, Suleiman S, Calleja N, et al
    The role of microRNA-9 in ovarian and cervical cancers: An updated overview.
    Eur J Surg Oncol. 2025;51:108546.
    PubMed    
    Abstract available

  220. ZHANG X, Yang J, Feng Q, Gu L, et al
    The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
    Environ Toxicol. 2025;40:902-911.
    PubMed    
    Abstract available

  221. ZHU Y, Shi X, Zhang S, Cui H, et al
    Prognostic value of circ_0000043/miR-590-5p in cervical cancer and regulation of tumor progression.
    Discov Oncol. 2025;16:879.
    PubMed    
    Abstract available

  222. ZHAI Q, Zhao L, Wang M, Li L, et al
    Integrated analysis of microbiome and metabolome reveals insights into cervical neoplasia aggravation in a Chinese cohort.
    Front Cell Infect Microbiol. 2025;15:1556153.
    PubMed    
    Abstract available

  223. JAASKELAINEN E, Karkkainen H, Palmgren JE, Haataja M, et al
    Implementing treatment according to the guidelines is of paramount importance in locally advanced cervical cancer: a real-world study.
    Front Oncol. 2025;15:1562067.
    PubMed    
    Abstract available

  224. WU F, Lu Z, Que J, Ma S, et al
    The safety of combining Endostar with concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer and the evaluation of its anti-angiogenic effects via transrectal contrast-enhanced ultrasound.
    Front Oncol. 2025;15:1514425.
    PubMed    
    Abstract available

  225. WANG Y, Hou H, Dong G, Zhang H, et al
    Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015-2023.
    Virol J. 2025;22:157.
    PubMed    
    Abstract available

  226. AKTARY ML, Bartel R, James A, Kima J, et al
    Cervical and breast cancer screening outcomes among Metis people in Alberta, Canada.
    BMC Womens Health. 2025;25:246.
    PubMed    
    Abstract available

  227. CHEN H, Wang Q, Kang M, Huang W, et al
    HPV-associated squamous cell carcinoma and adenocarcinoma in distinct cervical sites: a case report.
    BMC Infect Dis. 2025;25:732.
    PubMed    
    Abstract available

  228. ZHU X, Zhang L, Yu X, Yan P, et al
    Elucidating the tumor microenvironment interactions in breast, cervical, and ovarian cancer through single-cell RNA sequencing.
    Sci Rep. 2025;15:17846.
    PubMed    
    Abstract available

  229. PETTITT C, Ali A
    Trauma-informed practice for promotion of cervical cancer screening: an exploration of factors influencing engagement with cervical cancer screening.
    Br J Gen Pract. 2025;75.
    PubMed    
    Abstract available

  230. BASKARAN N, Pader A, Momin F, Khan R, et al
    Exploring the health inequalities and potential solutions to cervical screening uptake in primary care.
    Br J Gen Pract. 2025;75.
    PubMed    
    Abstract available

  231. MARTIN K, McNamara P
    Understanding the barriers contributing to 'missingness' of patients from deep-end practices within the cervical smear screening programme.
    Br J Gen Pract. 2025;75.
    PubMed    
    Abstract available

  232. DI MARTINO E, Bradley S, Khan T, Foy R, et al
    Improving cervical cancer screening uptake in general practice: a feedback intervention feasibility study.
    Br J Gen Pract. 2025;75.
    PubMed    
    Abstract available

  233. YU L, Han W, Zhang J, Liu G, et al
    Repurposing HIV protease inhibitors as senotherapeutic agents in cervical cancer: Dual targeting of CDK1/6-cell cycle arrest and p53/p21/p16 signaling axis.
    Biochem Biophys Res Commun. 2025;771:152040.
    PubMed    
    Abstract available

  234. FERNANDES A, Lunet N
    Human papillomavirus vaccination, cervical cancer screening, and acceptability of self-sampling: a cross-sectional study in vulnerable women.
    Eur J Cancer Prev. 2025 May 19. doi: 10.1097/CEJ.0000000000000975.
    PubMed    
    Abstract available

  235. MOHAMED SHAIE K, Abdulkadir Ali M, Andrea M, Yan H, et al
    The role of photodynamic therapy in treating LSIL in women with high-risk HPV: a literature review.
    Lasers Med Sci. 2025;40:237.
    PubMed    
    Abstract available

  236. ROSTAMI VARNOUSFADERANI M, Khoshnazar Z, Zeratie H, Hosseini Koukamari P, et al
    Optimizing HPV vaccine effectiveness: impact of vaccination age and dose schedule on immunogenicity and cervical cancer prevention.
    Front Public Health. 2025;13:1544220.
    PubMed    
    Abstract available

  237. AGRAWAL S, Padhan S, Panneerselvam S, Ramasamy S, et al
    Nurses at the forefront in cervical cancer: HPV vaccine promotion to combat the deadly disease in India.
    J Educ Health Promot. 2025;14:153.
    PubMed    
    Abstract available

  238. KERMANSHAHI AZ, Ebrahimi F, Taherpoor A, Eslami N, et al
    HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy.
    Virol J. 2025;22:156.
    PubMed    
    Abstract available

  239. FAYEHUN O, Apenteng P, Umar UA, Adebayo KO, et al
    Diagnosis of cancer in the South and North of Nigeria: duration and causes of delay.
    BMC Health Serv Res. 2025;25:738.
    PubMed    
    Abstract available

  240. ZHANG C, Tian W, Zhou X, Li L, et al
    ASO Author Reflections: Laparoscopic Radical Hysterectomy has Equivalent Survival Outcomes Compared with Open Abdominal Radical Hysterectomy in Early-Stage Low-Risk Cervical Cancer.
    Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-024-16767.
    PubMed    


  241. NEU M, Wohrl CM, Walter R, Balagiannis N, et al
    Multimodal chemoradiotherapy including interstitial brachytherapy enhances outcomes in FIGO stage IVA cervical cancer: a focus on tumor control and quality of life.
    Strahlenther Onkol. 2025 May 21. doi: 10.1007/s00066-025-02407.
    PubMed    
    Abstract available

  242. ZHANG B, Zhao W, Huang C, Lan Q, et al
    Optimized segmentation of overlapping cervical cells based on Mask2Former and denoising.
    Sci Rep. 2025;15:17715.
    PubMed    
    Abstract available

  243. FAN X, Liang X, Guo Y, Jin G, et al
    125I inhibits the progression of cervical cancer by upregulating the HSF1/PU.1/SYK signaling pathway and consequently enhancing the apoptotic response mediated by ROS/USP7/P53.
    Sci Rep. 2025;15:17690.
    PubMed    
    Abstract available

  244. CHEN X, Xu H, Zhao L, Jiang H, et al
    The role of PAX1 and JAM3 methylation in predicting the pathological upgrading of cervical intraepithelial neoplasia before conization.
    Sci Rep. 2025;15:17684.
    PubMed    
    Abstract available

  245. ASOUDEH-FARD A, Sis FF, Rahmani B, Kamranjam M, et al
    Inhibitory effects of tetraselmis algae extract on cervical cancer cell proliferation: a molecular and cellular approach.
    Mol Biol Rep. 2025;52:473.
    PubMed    
    Abstract available

  246. AKCA Y, Uzun E, Erkilic S
    Comprehensive Evaluation of the Utility of Cell Block Use in ThinPrep Liquid-Based Cervical Specimens.
    Turk Patoloji Derg. 2025;1.
    PubMed    
    Abstract available

  247. KOTAL H, Kalyani T, Lala A, R K, et al
    Development of a highly sensitive, label-free electrochemical immunosensor for p16INK4a detection: a step toward early cervical cancer diagnosis.
    Anal Methods. 2025 May 21. doi: 10.1039/d5ay00411.
    PubMed    
    Abstract available

  248. LIU Y, Zhao G, Kong Y, Zhou F, et al
    Detection of the Prognostic Gene CYB5D2 in Cervical Squamous Epithelial Lesions.
    Mediators Inflamm. 2025;2025:2360364.
    PubMed    
    Abstract available

  249. SHEN X, Sun H, Zhang S
    Comprehensive Single-Cell RNA Sequencing Analysis of Cervical Cancer: Insights Into Tumor Microenvironment and Gene Expression Dynamics.
    Int J Genomics. 2025;2025:5027347.
    PubMed    
    Abstract available

  250. TOGAMI S, Fufuzono N, Fukuda M, Kobayashi H, et al
    Indocyanine Green and Radioisotope Tracers for Sentinel Lymph Node Mapping in Early-Stage Cervical Cancer: A Prospective Comparative Study.
    Cureus. 2025;17:e82644.
    PubMed    
    Abstract available

  251. SHEN L, Zhou L, Xi X, Hou S, et al
    Retrospective analysis of 274 cases suspected vaginal intraepithelial neoplasia.
    Sci Rep. 2025;15:17506.
    PubMed    
    Abstract available

  252. CAO L, Abudureheman W, Shen G, Ouyang Y, et al
    LncRNA NEAT1 regulation of the miR-101-3p/RAC1 axis affects cervical cancer aerobic glycolysis and progression.
    Sci Rep. 2025;15:17436.
    PubMed    
    Abstract available

  253. BASIR FA, Blyuss KB, Raezah AA, Rahman B, et al
    Mathematical modelling of the role of Langerhans cells in the dynamics of HPV infection.
    Sci Rep. 2025;15:17505.
    PubMed    
    Abstract available

  254. DRYSDALE K, Creagh NS, Nightingale C, Whop LJ, et al
    Beyond words: operationalizing inclusive language in Australian cervical screening health promotion policy.
    Health Promot Int. 2025;40:daaf058.
    PubMed    
    Abstract available

  255. YE C, Liu Y, Huang H, Chen R, et al
    Risk-Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real-World Study.
    J Med Virol. 2025;97:e70404.
    PubMed    
    Abstract available

  256. HUANG Y, Liang F, Huang J, Jiang H, et al
    Improving Detection of CIN2+ and CIN3+ Lesions: Evaluation of E6/E7 mRNA, P16, and Ki-67, Individually and in Combination.
    J Med Virol. 2025;97:e70405.
    PubMed    
    Abstract available

  257. BI S, Zhou J, Xu M, Dai Z, et al
    Reevaluating BED in cervical cancer HDR brachytherapy: source decay and tissue-specific repair significantly impact radiobiological dose.
    Front Oncol. 2025;15:1407606.
    PubMed    
    Abstract available

  258. ALSHAMRANI A, Chuter R, Aznar M, Hoskin P, et al
    Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in cervical cancer.
    Acta Oncol. 2025;64:693-702.
    PubMed    
    Abstract available

  259. FATHI PS, Sofian M, Almasi-Hashiani A, Sadat Larijani M, et al
    Insufficient knowledge of Human Papillomavirus among reproductive-aged women from Arak, Iran.
    BMC Womens Health. 2025;25:238.
    PubMed    
    Abstract available

  260. LIU Y, Pan X, Zhang X, Tan B, et al
    Novel marker genes and small molecule drugs for radiotherapy resistance in cervical cancer identified based on single-cell multi-omics analysis.
    Discov Oncol. 2025;16:823.
    PubMed    
    Abstract available

  261. FITZPATRICK MB, Behrens CM, Hibler K, Parsons C, et al
    Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use: A Nonrandomized Clinical Trial.
    JAMA Netw Open. 2025;8:e2511081.
    PubMed    
    Abstract available

  262. YANG X, Chen S, Li Y, Peng J, et al
    Laparoscopic radical hysterectomy-karez technique for stage IB3 and IIA2 cervical cancer: a multicenter retrospective cohort study.
    Int J Surg. 2025 May 16. doi: 10.1097/JS9.0000000000002522.
    PubMed    
    Abstract available

  263. XIAO J, Niu R, Zhao F
    Single-cell and spatial transcriptome analysis revealed cellular heterogeneity of glycosyltransferases in cervical cancer, and identified GALNT3-negative epithelial cells as a protective factor: a retrospective cohort study based on public database.
    Int J Surg. 2025 May 16. doi: 10.1097/JS9.0000000000002520.
    PubMed    
    Abstract available

  264. LIU S, Yu T, Song L, Kalantar-Zadeh K, et al
    CRISPR/Cas on Microfluidic Paper-Based Analytical Devices for Point-of-Care Screening of Cervical Cancer.
    ACS Sens. 2025 May 19. doi: 10.1021/acssensors.5c00863.
    PubMed    
    Abstract available

  265. MUMPER M, Nolen L, Herget KA, Codden RR, et al
    Changes in Breast and Cervical Cancer Incidence by Stage at Diagnosis During the COVID-19 Pandemic in Utah.
    Cancer Med. 2025;14:e70952.
    PubMed    
    Abstract available

  266. RIVERA ROLON MDM, Gustafson E, Cole R, Matos J, et al
    Implementing 100% quality control in a cervical cytology workflow using whole slide images and artificial intelligence provided by the Techcyte SureView System.
    Cancer Cytopathol. 2025;133:e70019.
    PubMed    
    Abstract available

  267. SHI J, Wang L, Zhou M, Ge S, et al
    Harnessing unsupervised machine learning with [(18)F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Front Oncol. 2025;15:1486654.
    PubMed    
    Abstract available

  268. AKUOKU V, Ashaley MD
    Knowledge and Prevalence of Cervical Cancer Screening Among Women Receiving Prenatal Care in Accra, Ghana: A Cross-Sectional Study.
    Health Serv Insights. 2025;18:11786329251337851.
    PubMed    
    Abstract available

  269. DENSCHLAG D, Czogalla B, Heitz F, Kerkmann M, et al
    Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal Observational Study: A Quality Assurance Initiative of the AGO-Study Group and AGO-OK Uter
    Geburtshilfe Frauenheilkd. 2025;85:520-532.
    PubMed    
    Abstract available

  270. LI Y, Hong Y, Shen H, Zhou J, et al
    FXR activation suppresses NF-kappaB signaling, proliferation and migration in cervical cancer cells.
    Transl Cancer Res. 2025;14:2440-2456.
    PubMed    
    Abstract available

  271. NDUKWE MI, Pohankova D, Halada P, Laco J, et al
    First-Trimester Radical Hysterectomy for Bulky Cervical Cancer: A Case Report on Oncologic and Reproductive Considerations.
    Cureus. 2025;17:e82486.
    PubMed    
    Abstract available

  272. ZHOU L, Liu Y, Zhang Y, Hu F, et al
    ITGA5 promotes cervical cancer progression by regulating IMP3 recruitment of HK2 mRNA.
    Am J Transl Res. 2025;17:3031-3049.
    PubMed    
    Abstract available

  273. FRIDLJUNG J, Bergengren L, Ryen L, Lillsunde Larsson G, et al
    Modelling the cost-effectiveness of cervical cancer screening with HPV self-sampling and molecular triage for women aged 60-69 years.
    Discov Oncol. 2025;16:805.
    PubMed    
    Abstract available

  274. DING Q, Zhuang Y, Yang HY, Zhao XN, et al
    USP31 confers radio-resistance in cervical cancer cells via ferroptosis pathway by deubiquitinating and stabilizing GPX4.
    Biochem Biophys Res Commun. 2025;770:151990.
    PubMed    
    Abstract available

  275. HASHEMI SMA, Alipour AH, Emamifar S, Farhadi A, et al
    Epstein-Barr virus nuclear antigen 1 (EBNA1) increases the expression levels of MDM2 and MDM4 genes in HeLa cells: a review on MDM2 and MDM4 roles in cancer.
    BMC Res Notes. 2025;18:221.
    PubMed    
    Abstract available

  276. LIEN JY, Hii LA, Su PH, Chen LY, et al
    Exploring potential methylation markers for ovarian cancer from cervical scraping samples.
    Hum Genomics. 2025;19:56.
    PubMed    
    Abstract available

  277. GAO D, Wang X, Juan J, Pei Z, et al
    Association between knowledge of cervical cancer prevention and screening behaviors among women aged 20 to 49 years: a cross-sectional study in six provinces, China.
    BMC Public Health. 2025;25:1821.
    PubMed    
    Abstract available

  278. ELWES M, Koppolu BP, Lapuz C, Tacey M, et al
    From Normal to Optimal: Investigating Metabolic and Inflammatory Parameters as Predictors of Survival in Locally Advanced Cervical Cancer.
    Stud Health Technol Inform. 2025;327:572-576.
    PubMed    
    Abstract available

  279. SKARGA-BANDUROVA I, Sharifnia G, Biloborodova T
    Bias Detection in Histology Images Using Explainable AI and Image Darkness Assessment.
    Stud Health Technol Inform. 2025;327:203-207.
    PubMed    
    Abstract available

  280. PENG Y, Tang Q, Wu S, Zhao C, et al
    Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis.
    BMC Infect Dis. 2025;25:708.
    PubMed    
    Abstract available

  281. YE Z, Zhu L, Wei Y, Lin A, et al
    USP25-driven KIFC1 regulates MYCBP expression and promotes the progression of cervical cancer.
    Cell Death Dis. 2025;16:390.
    PubMed    
    Abstract available

  282. BENARD A, Alipour S, Mauny F, Grillot M, et al
    [Optimization of cervical cancer screening in France: a prospective multicenter clinical study].
    Gynecol Obstet Fertil Senol. 2025 May 14:S2468-7189(25)00121.
    PubMed    


  283. OUYANG Y, Abuduxikuer G, Abulimiti T, Abudurexiti G, et al
    Clinical performance of the SureX PCR HPV test versus hybrid capture assays (DH2/careHPV) in primary cervical cancer screening.
    Tumour Virus Res. 2025;19:200319.
    PubMed    
    Abstract available

  284. VAN DEN BORST E, Bell M, Op De Beeck K, Van Camp G, et al
    Lineages and sublineages of high-risk HPV types associated with cervical cancer and precancer: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2025 May 16:djaf118. doi: 10.1093.
    PubMed    
    Abstract available

  285. TAKATSU J, Murakami N, Okonogi N, Inoue T, et al
    Optimizing dwell time weight for interstitial needles in intracavitary/interstitial hybrid brachytherapy: balancing tumor coverage with organ sparing using the inverse planning technique.
    J Radiat Res. 2025;66:296-305.
    PubMed    
    Abstract available

  286. TEH TRD, de Leon VNO, Tantengco OAG
    Role of extracellular vesicles in the pathophysiology, diagnosis, and prognosis of gynecological cancers.
    Pathol Res Pract. 2025;270:155987.
    PubMed    
    Abstract available

  287. HOSSEINI MS, Sadeqi A, Heidari Z, Boozari M, et al
    A Comprehensive Review of Biologically Active Natural Products on Human Papillomavirus (HPV) at a Glance.
    Phytother Res. 2025;39:2262-2290.
    PubMed    
    Abstract available

  288. CORREA CM, Zeferino LC, Bahamondes L
    Association of intrauterine device use and risk of abnormal cervical cytology.
    Eur J Contracept Reprod Health Care. 2025;30:87-92.
    PubMed    
    Abstract available

  289. KEVAT S, Mistry A, Oza N, Majmudar M, et al
    Cancer Stem Cell Regulation as a Target of Therapeutic Intervention: Insights into Breast, Cervical and Lung Cancer.
    Cell Biochem Biophys. 2025;83:1521-1535.
    PubMed    
    Abstract available

  290. LIU K, Shi H, Gao L, Ye L, et al
    Endocervical adenocarcinoma with a micropapillary component: a clinicopathologic analysis in the setting of current WHO classification.
    Virchows Arch. 2025;486:1011-1021.
    PubMed    
    Abstract available

  291. SANDEFORD J, Herbst U, Lum T, Anderson L, et al
    High-grade squamous intraepithelial lesions and adenocarcinoma in situ with a negative HPV cervical screening test. The role of HPV-ISH testing: A retrospective review.
    Aust N Z J Obstet Gynaecol. 2025;65:297-300.
    PubMed    
    Abstract available

  292. DE OLIVEIRA RL, Valente ECA, Gadelha JGS, Witkin SS, et al
    Critical Evaluation of Pap Test Adherence to Routine Screening in Amazonas State, Brazil.
    Acta Cytol. 2025;69:144-153.
    PubMed    
    Abstract available

  293. KIMURA F, Ohshima K, Kanai R, Urata T, et al
    Image Quantification Analysis of Cytoplasmic Mucin and Interpretation of Mucin Color in Lobular Endocervical Glandular Hyperplasia.
    Acta Cytol. 2025;69:131-143.
    PubMed    
    Abstract available

  294. BJURBERG M, Hellman K, Sall TA, Staf C, et al
    Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer-a Swedish gynecologic cancer group (Swe-GCG) study.
    Acta Obstet Gynecol Scand. 2025 May 7. doi: 10.1111/aogs.15152.
    PubMed    
    Abstract available

  295. ERDAL JL, Serizawa RR, Rebolj M, Schroll JB, et al
    Outcomes associated with large loop excision of the cervical transformation zone in women 60-64 years of age: A population-based register study from Denmark.
    Acta Obstet Gynecol Scand. 2025;104:1112-1119.
    PubMed    
    Abstract available

  296. HUANG CC, Ayala-Peacock DN, Stephens SJ, Chino JP, et al
    Recent advances in gynecologic radiation oncology.
    Cancer. 2025;131:e35888.
    PubMed    
    Abstract available

  297. ZHOU J, Tang M, Lin C, Chen W, et al
    The Value of P16 Protein Detection in the Screening for High-Grade Squamous Intraepithelial and Higher Lesions of the Cervix by the Combined Detection of HR-HPV and TCT.
    Diagn Cytopathol. 2025;53:283-289.
    PubMed    
    Abstract available

  298. DESAI N, Towne W, Connelly CF, Baskota SU, et al
    Utility of CINtec PLUS in Identification of High-Grade Lesions on Short-Term Follow-Up in Patients With Negative Cytologic Interpretation.
    Diagn Cytopathol. 2025;53:265-271.
    PubMed    
    Abstract available

  299. EMINOWICZ G, Vaja S, Hackshaw A, McCormack M, et al
    Response to letter Re: Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.
    Eur J Cancer. 2025 Apr 22:115449. doi: 10.1016/j.ejca.2025.115449.
    PubMed    


  300. ZHU Y, Zhao C, Liu H, Li Y, et al
    Can contrast-enhanced ultrasound differentiate cervical lesions?
    Eur J Obstet Gynecol Reprod Biol. 2025;310:113998.
    PubMed    
    Abstract available

  301. PALUMBO M, Lavitola G, Di Filippo C, Foreste V, et al
    Impact of Human papillomavirus 9-valent vaccine on viral clearance after surgical treatment: A single-center retrospective observational study.
    Eur J Obstet Gynecol Reprod Biol. 2025;310:113994.
    PubMed    
    Abstract available

  302. BAE J, Kim U, Paik ES, Lim MC, et al
    Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria.
    Gynecol Oncol. 2025;197:91-95.
    PubMed    
    Abstract available

  303. GU J, Zheng W, Li F, Luo C, et al
    Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node metastasis which is comparable to stage IIIC.
    Gynecol Oncol. 2025;198:17-24.
    PubMed    
    Abstract available

  304. KALJOUW S, Jansen EEL, Schevenhoven VJC, de Kok IMCM, et al
    Should the age range of the Dutch hrHPV-based cervical cancer screening program be broadened? A modelling study using cohort effects.
    Int J Cancer. 2025 Apr 28. doi: 10.1002/ijc.35435.
    PubMed    
    Abstract available

  305. CHANDRAN A, Mackie A, Sasieni P, Arbyn M, et al
    Technical, legal and ethical framework of cancer audit in cervical screening - Summary of best practices for organised programmes delineated through an expert group consultation.
    Int J Cancer. 2025;157:32-40.
    PubMed    
    Abstract available

  306. BOWDEN SJ, Bodinier B, Paraskevaidi M, Kalliala I, et al
    DNA methylation signatures of cervical pre-invasive and invasive disease: An epigenome-wide association study.
    Int J Cancer. 2025;157:305-316.
    PubMed    
    Abstract available

  307. BJORGE T, Stoer NC, Hverven SK, Nygard M, et al
    Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study.
    Int J Cancer. 2025;157:251-259.
    PubMed    
    Abstract available

  308. ROMANISHIN A, Efimenko B, Katserov D, Agapov M, et al
    Comprehensive cross-sectional study of CIN prevalence, HPV genotyping, genetic alterations, and microbiota as molecular biomarkers for early cervical cancer detection: A pilot clinical study among women in Russia.
    Int J Gynaecol Obstet. 2025 May 5. doi: 10.1002/ijgo.70090.
    PubMed    
    Abstract available

  309. LI DM, Liu QY, Xue SL, Zeng X, et al
    Accuracy analysis of cervical cancer screening using urine and vaginal self-sampling versus clinician-collected samples: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70207.
    PubMed    
    Abstract available

  310. HEMIDA R, Barakat R, Nabil H, Hasan M, et al
    Cervical cancer elimination in low-resource countries: low-cost strategy.
    Int J Gynecol Cancer. 2025 Apr 11:101828. doi: 10.1016/j.ijgc.2025.101828.
    PubMed    


  311. HUANG Y, Yoh K, Szamreta EA, Xu X, et al
    Patterns of pembrolizumab use for recurrent cervical cancer.
    Int J Gynecol Cancer. 2025;35:101802.
    PubMed    
    Abstract available

  312. LEE J, Lin JB, Wang CH, Lin WH, et al
    Whole-uterine versus individualized-uterine radiotherapy in locally advanced cervical cancer: clinical outcome and toxicity.
    Int J Gynecol Cancer. 2025;35:101817.
    PubMed    
    Abstract available

  313. FALLAH PN, Citonje-Msadabwe S, Fundafunda S, Schmeler KM, et al
    Scale-up of cervical cancer prevention services in Zambia.
    Int J Gynecol Cancer. 2025;35:101816.
    PubMed    


  314. BIZZARRI N, Querleu D, Ramirez PT, Plante M, et al
    Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm trial with stopping rules (ENGOT-cx23/MITO/LASH trial).
    Int J Gynecol Cancer. 2025;35:101818.
    PubMed    
    Abstract available

  315. FRENEL JS, Roynard T, Loaec C, Ray-Coquard I, et al
    Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy management.
    Int J Gynecol Cancer. 2025;35:101908.
    PubMed    


  316. LOU J, Li Y, Li R, Guo Y, et al
    Association between magnetic resonance imaging-measured bone marrow cellularity and clinical outcomes among patients with cervical cancer treated with programmed cell death protein-1 inhibitors.
    Int J Gynecol Cancer. 2025;35:101808.
    PubMed    
    Abstract available

  317. DOSTALEK L, Brynda D, Marek R, Hederlingova J, et al
    Regression of high-grade squamous intraepithelial cervical lesions and associated risk factors (RECER).
    Int J Gynecol Cancer. 2025;35:101768.
    PubMed    
    Abstract available

  318. FALLAH PN, Salcedo MP, Nhacule E, Utui Y, et al
    A randomized clinical trial to assess the effectiveness of thermal ablation versus loop electrosurgical excision procedure for cervical cancer risk reduction in women living with HIV in Mozambique.
    Int J Gynecol Cancer. 2025 Apr 26:101905. doi: 10.1016/j.ijgc.2025.101905.
    PubMed    
    Abstract available

  319. NAVARRO AS, Ricotta G, Gauroy E, Martinez A, et al
    Urinary reconstruction using enterocystoplasty after partial cystectomy in surgical recurrence of cervical cancer.
    Int J Gynecol Cancer. 2025;35:101813.
    PubMed    


  320. ZEEVI G, Eitan R
    The art of prevention: merging creativity and medicine to transform cervical cancer awareness.
    Int J Gynecol Cancer. 2025;35:101909.
    PubMed    


  321. KNOTH J, Nout RA, Potter R, Mahantshetty DU, et al
    Distant metastasis after chemoradiation and IGABT in locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 10:S0360-3016(25)00436.
    PubMed    
    Abstract available

  322. SAPIENZA LG, Chapman CH, Jhavar S, Calsavara VF, et al
    Understanding hydronephrosis occurrence by an individual-kidney level analysis of all events post-chemoradiotherapy for locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 8:S0360-3016(25)00430.
    PubMed    
    Abstract available

  323. AHMED KA, Quick AM, Chon HS, Chern JY, et al
    Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results from a Phase II Multi-Institutional Study.
    Int J Radiat Oncol Biol Phys. 2025 May 14:S0360-3016(25)00446.
    PubMed    
    Abstract available

  324. LI S, Oatman E, Tanyi J, Kim SH, et al
    Detection of Human Papillomavirus DNA on Red Blood Cells in Patients With Cervical Cancer.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005932.
    PubMed    
    Abstract available

  325. FRIEDLOVA N, Bortlikova L, Dosedelova L, Uhrik L, et al
    IFITM1 as a modulator of surfaceome dynamics and aggressive phenotype in cervical cancer cells.
    Oncol Rep. 2025;53:71.
    PubMed    
    Abstract available

  326. YOON HY, Kim JM, Jeong YY, Lee YH, et al
    Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion.
    BMC Cancer. 2025;25:811.
    PubMed    
    Abstract available

  327. LI ZR, Wang YF, Zuo CR, Men JS, et al
    Unlocking the potential of immune checkpoint inhibitors in advanced cervical cancer: a meta-analysis and systematic review.
    BMC Cancer. 2025;25:863.
    PubMed    
    Abstract available

  328. LI K, Huang F, Zhang T, Yang F, et al
    HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study.
    BMC Cancer. 2025;25:885.
    PubMed    
    Abstract available

  329. ZHOU Q, Song B, He Y, Zhang Z, et al
    Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in cervical cancer.
    PLoS One. 2025;20:e0322387.
    PubMed    
    Abstract available

  330. RAPAJIC-MORAN I, Filipic B, Rajkovic D, Rakic M, et al
    Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach.
    PLoS One. 2025;20:e0322584.
    PubMed    
    Abstract available

  331. NOREEN K, Khalid SN, Javaid M, Khan SA, et al
    Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination in Pakistan: A protocol for a mixed-method study to explore community perceptions and health system preparedness.
    PLoS One. 2025;20:e0323826.
    PubMed    
    Abstract available

  332. ZARGARAN H, Ghaemi A, Shenagari M, Samadi M, et al
    Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies.
    PLoS One. 2025;20:e0312979.
    PubMed    
    Abstract available

  333. DANIELS J, Kyei KA, Frimpong-Boateng PD, Nyantakyi AY, et al
    Sexual function outcomes in prostate and cervical cancer patients treated with radiotherapy in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2025;20:e0324662.
    PubMed    
    Abstract available

  334. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
    Correction: Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
    PLoS One. 2025;20:e0324971.
    PubMed    
    Abstract available

  335. GOVINDSAMY K, Noll S, Blose N, Amponsah-Dacosta E, et al
    Effectiveness of integrating cervical cancer prevention strategies into HIV care programmes: A mixed-methods systematic review protocol.
    PLoS One. 2025;20:e0306496.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;